Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
The Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 and caused continual outbreaks worldwide with high mortality. However, no effective anti-MERS-CoV drug is currently available. Recently, numerous evolutionary studies have suggested that MERS-CoV originated from bat coronavi...
Main Authors: | Shuai Xia, Qiaoshuai Lan, Jing Pu, Cong Wang, Zezhong Liu, Wei Xu, Qian Wang, Huan Liu, Shibo Jiang, Lu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/11/1/56 |
Similar Items
-
Serological evidence of MERS-CoV and HKU8-related CoV co-infection in Kenyan camels
by: Wei Zhang, et al.
Published: (2019-01-01) -
Genomic Characterization of Diverse Bat Coronavirus HKU10 in Hipposideros Bats
by: Ning Wang, et al.
Published: (2021-09-01) -
More and More Coronaviruses: Human Coronavirus HKU1
by: Patrick C. Y. Woo, et al.
Published: (2009-06-01) -
A New Bat-HKU2–like Coronavirus in Swine, China, 2017
by: Lang Gong, et al.
Published: (2017-09-01) -
A Fusion Peptide in the Spike Protein of MERS Coronavirus
by: Entedar A. J. Alsaadi, et al.
Published: (2019-09-01)